Prestige Consumer Healthcare Finalizes Breathe Right Acquisition
Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment
Neutral
Importance
7
Price
$47.87
Mkt Cap
$2.265B
52W Low
$42.62
52W High
$85.57
52W Position
12% above low
Off High
44% below high
Rel. Volume
0.8× avg
Market data snapshot near publication time
PBH is trading near its 52-week low of $42.62 (12% above the low).
Summary
Prestige Consumer Healthcare Inc. has completed its acquisition of the Breathe Right® brand. This finalizes the strategic agreement that was initially announced via an 8-K filing on March 20, 2026. The completion integrates a well-known over-the-counter product into Prestige's portfolio, executing on its stated growth strategy.
At the time of this announcement, PBH was trading at $47.87 on NYSE in the Trade & Services sector, with a market capitalization of approximately $2.3B. The 52-week trading range was $42.62 to $85.57. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.
Price Chart
PBH - Latest Insights
PBH
Aug 06, 2026, 6:15 AM EDT
Price at Filing:
$52.97
Real-time Price:
$45.40
Change:
-$7.57 (-14%)
Market Cap:
$2.144B
PBH
Aug 06, 2026, 6:04 AM EDT
Price at Filing:
$52.97
Real-time Price:
$45.40
Change:
-$7.57 (-14%)
Market Cap:
$2.144B
PBH
Aug 06, 2026, 6:02 AM EDT
Price at Filing:
$52.97
Real-time Price:
$45.40
Change:
-$7.57 (-14%)
Market Cap:
$2.144B
PBH
Jul 15, 2026, 4:03 PM EDT
Price at Filing:
$48.36
Real-time Price:
$45.40
Change:
-$2.96 (-6%)
Market Cap:
$2.144B
PBH
Jul 06, 2026, 8:05 AM EDT
Price at Filing:
$49.42
Real-time Price:
$45.40
Change:
-$4.02 (-8%)
Market Cap:
$2.144B